SPI is a wholly owned subsidiary of Sumitomo Corporation and is an integrated service company specializing in the area of pharmaceutical development and commercialization with 90 professional staffs at 5 locations including own API warehouse and analytical laboratory in Japan. SPI has a good track record in activities such as, exclusive agent of ATCC (the world's largest gene/cell bank for research) of the USA, supply of starting materials, intermediates and active pharmaceutical raw materials for pharmaceuticals, and intermediation/consultation services in license/co-research arrangements of promising drugs/diagnostics/technologies originating from domestic and foreign bio-ventures, pharmaceutical companies, universities and institutes.